Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Cory

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Advances in Enzyme Regulation|January 1, 1996
Differences in the properties of mammalian ribonucleotide reductase toward its substratesJ G Cory, D L Downes, A H Cory
Cancer Communications|January 1, 1989
Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductaseG L Carter, D P Thompson, J G Cory
Cancer Research|December 1, 1979
Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cellsJ G Cory, J C Breland, G L Carter
Advances in Enzyme Regulation|October 8, 1998
Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agentsA H Cory, A W He, J G Cory
Cancer Research|August 1, 1990
5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in cultureJ G Cory, M C Halley, A Jeney, et al.
Journal of the National Cancer Institute|June 1, 1988
Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cellsG Weckbecker, A Weckbecker, E J Lien, et al.
Cancer Research|February 15, 1987
Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cellsG Weckbecker, A Weckbecker, E J Lien, et al.
Cancer Biochemistry Biophysics|June 1, 1985
Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductaseJ G Cory, A Sato, P E Bacon, et al.
Advances in Enzyme Regulation|June 1, 2000
Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductaseJ G Cory, L Somerville, A W He, et al.
Biochemical Pharmacology|January 20, 1994
2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in cultureA H Cory, V Samano, M J Robins, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Advances in Enzyme Regulation|January 1, 1996
Differences in the properties of mammalian ribonucleotide reductase toward its substratesJ G Cory, D L Downes, A H Cory
Cancer Communications|January 1, 1989
Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductaseG L Carter, D P Thompson, J G Cory
Cancer Research|December 1, 1979
Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cellsJ G Cory, J C Breland, G L Carter
Advances in Enzyme Regulation|October 8, 1998
Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agentsA H Cory, A W He, J G Cory
Cancer Research|August 1, 1990
5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in cultureJ G Cory, M C Halley, A Jeney, et al.
Journal of the National Cancer Institute|June 1, 1988
Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cellsG Weckbecker, A Weckbecker, E J Lien, et al.
Cancer Research|February 15, 1987
Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cellsG Weckbecker, A Weckbecker, E J Lien, et al.
Cancer Biochemistry Biophysics|June 1, 1985
Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductaseJ G Cory, A Sato, P E Bacon, et al.
Advances in Enzyme Regulation|June 1, 2000
Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductaseJ G Cory, L Somerville, A W He, et al.
Biochemical Pharmacology|January 20, 1994
2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in cultureA H Cory, V Samano, M J Robins, et al.
Pageof 12